Skip to main content

Page last checked

How-to · reconstitution

How to reconstitute IGF-1 LR3 1 mg

In this example, 1 mL of bacteriostatic water in a 1 mg IGF-1 LR3 vial gives 1.00 mg/mL. An example 40 mcg amount is then 4.0 units on a U-100 syringe.

This example lands on a syringe line. More water makes a weaker mix and a bigger draw. Less water makes a stronger mix and a smaller one. The amount of IGF-1 LR3 stays the same. Use the diluent and volume specified for your product; the arithmetic alone does not choose them.

What matters first

Example water volume
1 mL
Resulting strength
1.00 mg/mL
Example 40 mcg dose
4.0 U-100 units

No completed controlled human trial has shown which dose works for IGF-1 LR3. The range people report using is not a study result, tested schedule or recommendation.

no human dose shown to work

How much bacteriostatic water for a 1 mg IGF-1 LR3 vial?

◆ Unique to the 1 mg vialU-100 example draws
Water addedConcentrationPer U-100 unitExample: 40 mcg =
1 mL1.00 mg/mL10 mcg4.0 units
2 mL0.50 mg/mL5 mcg8.0 units

Straight arithmetic: concentration = 1 mg ÷ liquid volume, and 1 U-100 unit = 0.01 mL. The example column shows the math at 40 mcg; it is not a dose recommendation.

The table compares possible concentrations; it does not establish which diluent or volume suits your product. Follow its dispensing instructions.

“Hard to measure” means the example draw is below two U-100 units. “Won’t fit” means it exceeds this syringe’s capacity.

IGF-1 LR3 1 mg vial: example mixing volumes. Each row is what that amount draws on a U-100 syringe. 1 mL makes 1.00 mg/mL, or 10 mcg a unit, and 40 mcg is 4 units. 2 mL makes 0.50 mg/mL, or 5 mcg a unit, and 40 mcg is 8 units. The barrel drawn here is filled to 4 units, the draw at 1 mL. The sum is 1 mg divided by the liquid volume. One U-100 unit is 0.01 mL.
The 1 mg vial at 1 mL on a U-100 barrel. 40 mcg fills to 4.0 units, at 1.00 mg/mL.

Medically reviewed by Kenneth Montecillo, MD2026-09-07open the primary sources

What is IGF-1 LR3?

IGF-1 LR3 is a re-engineered insulin-like growth factor 1. The changes stop your carrier proteins holding it back, so it stays active far longer than the natural version.

How many units is a documented dose from this vial?

The table above uses one worked example. These are the published quantities, converted into marks on a U-100 barrel at each listed liquid volume for a 1 mg vial. Where a quantity was never studied by injection, the row says so.

20–40 mcg — reported, not studied

20–40 mcg once a day, ideally after training, under the skin. Runs of four to six weeks with an equal break follow it. Published research on this analogue is limited to animals and cells. No study in a person has ever been registered.

Water addedConcentrationDraw, low to high
1 mL1.00 mg/mL2.0 to 4.0 units
2 mL0.50 mg/mL4.0 to 8.0 units

indirect evidenceDominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, Ruchała M. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol 2026 — tabulates self-reported online dosing patterns beside the clinical doses, stating the reported values must not be read as clinically validated, regulatory-approved or safe · retrieved 2026-08-12

The stronger vial produces shorter whole-unit readings

This vial has ten times the powder of the smaller size. With the same water, the same dose takes one-tenth as much liquid. Both choices land on syringe lines, but one mark is still a large share of each short draw.

3Read the full vial record — 3 notes

Both readings are short despite landing on a line

Each example ends on a whole-unit mark, but a one-line difference is a substantial fraction of a short draw. The exact result therefore needs to be compared with the markings and measurement limits of the actual equipment.

The smaller vial example produces longer readings at the same liquid volumes. Both the concentration and draw change with vial strength, so a unit number needs its accompanying inputs rather than a judgment that one vial is more forgiving.

Twenty-five draws, with no clock to set against them

The vial divides into twenty-five worked amounts. No product-specific storage date is assigned here, so the count does not establish twenty-five weeks of use.

Reported schedules are not validated dosing instructions. They also do not establish the stability of a separately prepared product. The portion count cannot identify an appropriate treatment duration or a safe period to keep unused solution.

The sums are exact and the quantity they start from is not a dose

Everything in the table follows from the strength printed on the glass and the water added. It would follow just as exactly from a figure somebody invented. The figure here is a record of what people do, not the result of any study.

The published work on this analogue is animal and manufacturing research: lactating mice, fetal sheep heart cells, a rat gut, a mouse brain. Those cited sources do not establish a human injection dose for this analogue. An exact conversion does not turn the reported amount into a studied regimen or verify what a particular vial contains.

How do you mix it, step by step?

  1. Wipe both stoppers with an alcohol swab and let them dry.
  2. Check the product’s mixing instructions for the correct diluent and volume before drawing it up.
  3. Let the water run slowly down the inside wall of the IGF-1 LR3 vial, rather than jetting it onto the powder.
  4. Follow the product’s instructions for mixing and checking the solution before use. Do not assume every powder uses the same method.
  5. Store it as the dispensing label directs. What happens after mixing differs by product — some labels direct against refrigerating the mixed solution at all.

What if your water volume is not on the table?

The calculator lets you enter your product’s vial strength and mixing volume, then shows the arithmetic for your syringe.

Open the IGF-1 LR3 calculator →

Questions readers ask

How much BAC water for 1mg of IGF-1 LR3?

For a 1 mg vial, the page offers 1 mL and 2 mL mixes. A 40 microgram amount then equals 4 units or 8 units on a U-100 syringe.

Both land on a printed line, which sounds like the good outcome and is not. On a four-unit draw, one line is a quarter of everything in the syringe. The 0.1 mg vial sold under the same name reads ten times longer.

How long does a 1mg vial of IGF-1 LR3 last?

At the 40 microgram worked amount, the vial contains twenty-five draws. No published source says how long the mixed solution keeps.

The pattern a peer-reviewed review writes down is once daily, in runs of four to six weeks with an equal break. Against that, one vial covers most of a run. How long the surplus stays what it was is not something this page knows.

What is the dosing for IGF-1 LR3?

There is no published human dose. A ClinicalTrials.gov search in August 2026 returned no registered study of this analogue at all.

One peer-reviewed review tabulates what people give themselves, 20 to 40 micrograms once daily, and footnotes that row itself. The footnote says no peer-reviewed clinical study reports a dosing regimen for it in humans. That is a record of a practice, not a dose.

How to properly use IGF-1 LR3?

Nobody can answer that from published work, because no study of this analogue in a person has ever been registered. Catalogues list it as a cell-culture and bioprocessing reagent.

What exists is animal and manufacturing research: mouse lactation, fetal sheep heart cells, a rat gut, and a mouse model of Alzheimer’s disease. In that last one it remodelled amyloid plaque without preserving cognition. None of it describes use in a person.

Where to read next about IGF-1 LR3

The arithmetic on this page is only half the question. These are the pages that carry the other half.

1primary source, each with the day we read it — open the documents used on this page